Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Avidity Biosciences Inc (RNA)

  • Technical Exchange News
  • Feb. 26, 2026, 08:38 UTC
  • 45
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Avidity Biosciences, Inc. - Common Stock. New value: Avidity Biosciences, Inc. - Common Stock.

Comment Full text

CASI Pharmaceuticals Inc. (CASI)

  • Technical Exchange News
  • Feb. 26, 2026, 08:38 UTC
  • 45
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: CASI Pharmaceuticals, Inc. - Ordinary Shares.

Comment Full text

CASI Pharmaceuticals Inc. (CASI)

  • Technical Exchange News
  • Feb. 26, 2026, 08:38 UTC
  • 35
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: CASI Pharmaceuticals, Inc. - Ordinary Shares. New value: CASI Pharmaceuticals, Inc. - Ordinary Shares.

Comment Full text

Avidity Biosciences Inc (RNA)

  • Technical Exchange News
  • Feb. 26, 2026, 08:38 UTC
  • 43
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Avidity Biosciences, Inc. - Common Stock.

Comment Full text

Avidity Biosciences Inc (RNA)

  • Technical Exchange News
  • Feb. 26, 2026, 08:38 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Avidity Biosciences, Inc. - Common Stock.

Comment Full text

Rain Therapeutics Inc (was acquired by Pathos AI, Inc. (“Pathos”) on 13/12/2023) (RAIN)

  • Technical Exchange News
  • Feb. 26, 2026, 02:57 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Outlook Therapeutics Inc. (OTLK)

  • Technical Exchange News
  • Feb. 26, 2026, 02:57 UTC
  • 30
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CASI Pharmaceuticals Inc. (CASI)

  • Technical Exchange News
  • Feb. 26, 2026, 02:57 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

CASI Pharmaceuticals Inc. (CASI)

  • Technical Exchange News
  • Feb. 26, 2026, 00:53 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: CASI Pharmaceuticals, Inc. - Ordinary Shares.

Comment Full text

CASI Pharmaceuticals Inc. (CASI)

  • Technical Exchange News
  • Feb. 26, 2026, 00:53 UTC
  • 25
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: CASI Pharmaceuticals, Inc. - Ordinary Shares. New value: CASI Pharmaceuticals, Inc. - Ordinary Shares.

Comment Full text
  • Previous
  • 323
  • 324
  • 325
  • 326
  • 327
  • Next

Search

News categories

  • Technical Exchange News(14235)
  • Event(6229)
  • SEC News(366957)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(225324)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin